Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company’s lead program is pemvidutide, a ...

Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...

A research team from Virginia Commonwealth University has found that a drug currently in clinical trials for brain disorders ...

Ona Treatment Center announces updated TRICARE-approved alcohol rehabilitation services for active military members in ...